Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.87B | 5.47B | 5.76B | 5.22B | 5.12B | 3.33B |
Gross Profit | 2.40B | 2.22B | 1.66B | 1.37B | 1.66B | 970.00M |
EBITDA | 2.65B | 4.94B | 5.30B | 9.90B | 730.00M | 213.00M |
Net Income | 7.81B | 6.61B | 10.11B | 18.73B | 7.45B | 3.77B |
Balance Sheet | ||||||
Total Assets | 69.11B | 61.82B | 65.08B | 71.34B | 55.73B | 35.77B |
Cash, Cash Equivalents and Short-Term Investments | 18.29B | 18.99B | 20.87B | 13.57B | 6.03B | 8.02B |
Total Debt | 16.55B | 16.24B | 16.91B | 17.16B | 9.12B | 3.97B |
Total Liabilities | 21.16B | 20.53B | 20.45B | 20.82B | 12.54B | 6.46B |
Stockholders Equity | 47.90B | 41.26B | 44.59B | 50.42B | 43.07B | 29.10B |
Cash Flow | ||||||
Free Cash Flow | 1.35B | 978.00M | -349.00M | -817.00M | 54.00M | -310.00M |
Operating Cash Flow | 1.42B | 1.04B | -120.00M | -605.00M | 159.00M | -209.00M |
Investing Cash Flow | 12.88B | 209.00M | 12.64B | 4.39B | -3.22B | 2.33B |
Financing Cash Flow | -6.89B | -8.12B | -12.45B | 2.40B | 2.45B | -46.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $24.32B | 13.05 | 48.41% | ― | 17.81% | 1175.52% | |
76 Outperform | $27.59B | 22.30 | 14.37% | 0.94% | 4.59% | 83.27% | |
74 Outperform | $26.39B | 221.24 | 5.77% | ― | 64.12% | ― | |
73 Outperform | $29.96B | 8.54 | 9.85% | ― | -1.33% | 32.92% | |
73 Outperform | $102.68B | 316.83 | 4.41% | ― | 23.35% | ― | |
67 Neutral | $122.02B | 10.85 | 27.29% | 0.20% | 16.14% | ― | |
61 Neutral | $41.40B | -1.28 | -14.21% | 3.95% | 2.45% | -73.69% |